After Setbacks, Sanofi/GlaxoSmithKline COVID Vaccine Performs Well in Early Trial

Title: After Setbacks, Sanofi/GlaxoSmithKline COVID Vaccine Performs Well in Early Trial
Category: Health News
Created: 5/17/2021 12:00:00 AM
Last Editorial Review: 5/17/2021 12:00:00 AM